À propos de cet article

Citez

1. Awad AM, Bradley MC, Fernandez-Del-Rio L, Nag A, Tsui HS, Clarke CF. Coenzyme Q10 deficiencies: pathways in yeast and humans. Essays Biochem. 2018;62:361-76.10.1042/EBC20170106605671729980630 Search in Google Scholar

2. Lee SQ, Tan TS, Kawamukai M, Chen ES. Cellular factories for coenzyme Q10 production. Microb Cell Fact. 2017;39:1-16.10.1186/s12934-017-0646-4533573828253886 Search in Google Scholar

3. Macunluoglu B, Kaya Y, Atakan A, Ari E, Kaspar C, Demir H. Serum CoQ10 levels are associated with coronary flow reserve in hemodialysis patients. Hemodial Int. 2013;17:339-45.10.1111/hdi.1200123185999 Search in Google Scholar

4. Singh RB, Kumar A, Niaz MA, Singh RG, Gujrati S, Singh VP. Randomized double blind placebo controlled trial of CoQ10 in chronic renal failure. J Nutr Environ Med. 2000;10:281-8.10.1080/13590840020013266 Search in Google Scholar

5. Mehmetoglu I, Yerlikaya FH, Kurban S, Erdem SS, Tonbul Z. Oxidative stress markers in hemodialysis and peritoneal dialysis patients, including coenzyme Q10 and ischemia-modified albumin. Int J Artif Organs. 2012;35:226-32.10.5301/ijao.500007822461118 Search in Google Scholar

6. Anupama S, Pragnesh P, Nishkruti M, Pankti D. Effect of coenzyme Q10 alone and it’s combination with pentoxifylline in cisplatin-induced nephrotoxicity in rats. J Pharm Sci Bioscientific Res. 2016;6: 790-800. Search in Google Scholar

7. Sayed-Ahmed MM, Nagi MN. Thymoquinone supplementation prevents the development of gentamicin-induced acute renal toxicity in rats. Clin Exp Pharmacol Physiol. 2007;34:399-405.10.1111/j.1440-1681.2007.04560.x17439407 Search in Google Scholar

8. Tamura Y, Tanabe K, Kitagawa W, Uchida S, Schreiner GF, Johnson RJ, Nakagawa T. Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages. Am J Physiol Renal Physiol. 2012;303:F339-49.10.1152/ajprenal.00158.201222622455 Search in Google Scholar

9. Ragheb A, Attia A, Eldin WS, Elbarbry F, Gazarin S, Shoker A. The protective effect of thymoquinone, an anti-oxidant and anti-inflammatory agent against renal injury: a review. Saudi J Kidney Dis Transpl. 2009;20:741-52. Search in Google Scholar

10. Nicolantonio JJ, Bhutani J, McCarty MF. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart 2015;2:e000326.10.1136/openhrt-2015-000326462023126512330 Search in Google Scholar

11. El-Sheikh AA, Morsy MA, Mahmoud MM, Rifaai RA, Abdelrahman AM. Effect of coenzyme-q10 on Doxorubicin-induced nephrotoxicity in rats. Adv Pharmacol Sci. 2012;2012:981461.10.1155/2012/981461353399523346106 Search in Google Scholar

12. Abdullah AG. Age related changes of submandibular salivary glands: Anatomical and histological study. MSc. Thesis; 2005 Search in Google Scholar

13. Al Khateeb IA. A histological study on the development of human epidermis. MSc. Thesis; 1987:52-4. Search in Google Scholar

14. Littarru GP, Tiano L. Bioenergetic and antioxidant properties of coenzyme Q10: Recent developments. Mol Biotechnol. 2007;37:31-7.10.1007/s12033-007-0052-y17914161 Search in Google Scholar

15. Barakat A, Shegokar R, Dittgen M. Coenzyme Q10 oral bioavailability: effect of formulation type. J Pharm Inv. 2013;43: 431-51.10.1007/s40005-013-0101-4 Search in Google Scholar

16. Al-Megrin WA, Soliman D, Kassab RB, Metwally DM, Ahmed EAM, El-Khadragy MF. Coenzyme Q10 activates the antioxidant machinery and inhibits the inflammatory and apoptotic cascades against lead acetate-induced renal injury in rats. Front Physiol. 2020;11:64.10.3389/fphys.2020.00064702061532116774 Search in Google Scholar

17. López-Lluch G, Del Pozo-Cruz J, Sánchez-Cuesta A, Cortés-Rodríguez AB, Navas P. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. Nutrition. 2019;57:133-40.10.1016/j.nut.2018.05.02030153575 Search in Google Scholar

18. Alkharfy KM, Al-Daghri NM, Al-Attas OS, Alokail MS. The protective effect of thymoquinone against sepsis syndrome morbidity and mortality in mice. Int Immuno-pharmacol. 2011;11:250-410.1016/j.intimp.2010.11.03221145996 Search in Google Scholar

19. Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A. Oxidative stress and reactive oxygen species. Contrib Nephrol. 2005;149:240-60.10.1159/00008568615876848 Search in Google Scholar

20. Gokbel H, Gokbel H, Turk S, Okudan N, Atalay H, Belviranli M, Gaipov A, Solak Y. Effects of coenzyme Q10 supplementation on exercise performance and markers of oxidative stress in hemodialysis patients: A double-blind placebo-controlled crossover trial. Am J Ther. 2016;23:e1736-e1743.10.1097/MJT.000000000000016626844861 Search in Google Scholar

21. Koyner JL, Sher Ali R, Murray PT. Antioxidants. Do they have a place in the prevention or therapy of acute kidney injury? Nephron Exp Nephrol. 2008;109(4):e109-17.10.1159/00014293518802373 Search in Google Scholar

22. Durvasula RV, Shankland SJ. The renin-angiotensin system in glomerular podocytes: mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep. 2006;8:132-8.10.1007/s11906-006-0009-816672146 Search in Google Scholar

23. Farrag AR, Ibrahim RA, El-Sayed SN. Protective effect of Coenzyme Q10 against gentamicin induced acute renal failure in mice. J Biosci Appl Res. 2016;2:401-6.10.21608/jbaar.2016.108533 Search in Google Scholar

eISSN:
2300-6676
ISSN:
2084-980X
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy